What this university is, in practice
Wolverhampton's fee is not published against this course. The university publishes fee bands, the MPharm is not explicitly mapped to one, and the €21,623 shown here is the laboratory-based band rate applied on the reasoning that pharmacy is a lab programme. It is the only fee in this block reached by inference rather than by a course-specific figure.
A band rate, not a course rate
Our record is unusually explicit about its own reasoning here. The university publishes fee bands — an undergraduate non-laboratory rate and a laboratory rate — but this course is not explicitly mapped to either on the course page. The confirmed figure of £18,700 per year comes from the official 2026/2027 international fees table as the undergraduate laboratory-based band, applied because the MPharm is a laboratory programme. The evidence note records that this is a band rate, not a course-specific one, and names the date and the editorial approver.
The inference is sound — an MPharm is plainly laboratory-based — but it is still an inference, and that changes what the number is worth. Every other fee in this block is a figure a university published against the course you would enrol on. This one is a figure this site selected from a table.
The gap between the bands is what is at stake: the non-laboratory rate is £17,600, about €20,351, against £18,700 or about €21,623 for laboratory. Roughly €1,272 a year, €5,088 across the degree, riding on a classification the course page does not state.
The action that resolves it is a short email asking which band the MPharm sits in. That converts the largest uncertainty on this page into a fact, and it is worth doing before comparing Wolverhampton against Lincoln or Teesside on a €400 difference.
Where it lands if the inference holds
At €21,623 a year, four years is roughly €86,500 in tuition. Wolverhampton's living costs run about €10,400 a year on this site's presets — the same figure as Lincoln, Middlesbrough and Sunderland — so four years adds €41,600 and the all-in total is about €128,092.
That places it second cheapest of the five profiled today, €1,852 above Lincoln and €1,388 below Teesside across the whole degree. Those margins are narrow enough that the band question genuinely decides the ranking: if the MPharm were charged at the non-laboratory rate instead, Wolverhampton would be the cheapest UK pharmacy option in this batch by a clear margin.
This is the only page in the pass where the fee's evidential basis, rather than its size, is the thing worth acting on.
Shortlisted applicants attend an interview
The published requirement is 120 UCAS points at A level BBB, with chemistry at a minimum of C plus another of biology, chemistry, mathematics or physics, and IELTS 7.0 overall with a minimum of 6.5 in each component. Shortlisted applicants face a group situational-judgement task and a short numeracy assessment, plus professional health, character and background checks.
The award is a four-year MPharm (Hons) from the School of Pharmacy. English is the teaching and placement language, so there is no local-language requirement of the kind that applies across the non-English-speaking countries profiled elsewhere in this set.
The UCAS pharmacy calendar applies — equal-consideration deadline 14 January 2026 at 18:00 UK time, final application date 24 September 2026 subject to vacancies — with the standing caution that high-demand MPharm courses may close earlier and live availability controls.
Who this suits
Applicants willing to email the university and ask which fee band the MPharm sits in — because €5,088 across the degree depends on an answer the course page does not give.
Return-pathway evidence
This is a pharmacy program, so the World Directory of Medical Schools listing and ECFMG Sponsor Note evidence this site carries for medicine does not apply, and the catalog holds no school-level medical registry record for it. A four-year UK MPharm does not meet the stated post-2003 five-year minimum on duration alone, so this degree does not by itself support the FPGEC route to US registration — confirm your position with the NABP and your intended state board. For Canada, the Pharmacy Examining Board of Canada says eligible UK graduates may qualify for the streamlined pathway after Document Evaluation. Verify both directly with the relevant regulator before enrolling; nothing here establishes eligibility for examination, registration, or licensure.
Written from the verified catalog and the official sources linked on this page. Sources last checked 2026-07-12; profile updated 2026-08-12. Approver: EuroMedGuide AI editorial pipeline. Figures quoted here are gated against the catalog by npm run validate:guide-stats.